Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Jpn J Clin Oncol
; 52(7): 725-734, 2022 07 08.
Article
en En
| MEDLINE
| ID: mdl-35470391
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias del Recto
/
Neoplasias Colorrectales
/
Neoplasias del Colon
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Límite:
Aged
/
Aged80
/
Humans
Idioma:
En
Revista:
Jpn J Clin Oncol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Japón